Machine learning nominates a postpartum microRNA associated with later diabetes
Source check: Source checked. Not independent scientific confirmation.
Finding: LASSO-based screening nominated plasma microRNAs in women with previous gestational diabetes. In a separate 82-person sample set from the same longitudinal cohort, miR-369-3p remained associated with later type 2 diabetes after adjustment and multiple-testing correction. Adding it to clinical factors raised apparent AUC from 0.83 to 0.92, with overlapping confidence intervals. The final prediction model was evaluated after marker selection in that sample; prospective clinical utility remains untested.
Technology: LASSO logistic regression; bootstrap feature selection
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- L1-penalized logistic regression and repeated bootstrap selection prioritize microRNAs for subsequent measurement and outcome-association analysis.
- Test and result
- Twenty-one-person discovery screening and separate 82-person biomarker measurements within a 103-woman longitudinal cohort.
- Limitation / still unknown
- Independent-cohort replication, causal microRNA function and frozen-model prospective prediction remain unestablished; final-model performance can be optimistic.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://link.springer.com/content/pdf/10.1007/s00125-021-05429-z.pdf
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 21 Nov 2026. Review scope: Primary relevant model Methods, Results and limitations; exact primary identity and current primary PubMed correction/retraction relationships checked..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.